Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Clogged (nuclear) pores lead to febrile encephalopathy

June 12, 2019

Cognitive deficits ameliorated in mouse Alzheimer's models

June 11, 2019

Topline data presented from phase II study of NYX-2925 in patients with fibromyalgia

June 11, 2019

Identification and characterization of a fluorinated indole-imidazole as a 5-HT7 receptor agonist

June 7, 2019

American BriVision reports phase II data on ABV-1504 for major depressive disorder

June 7, 2019

Nasally administered olanzapine INP-105 more rapidly absorbed than other formulations

June 7, 2019

The University of Kansas, Victoria Link disclose mu-opioid receptor agonists

June 7, 2019

Axovant presents 6-month follow-up data from first cohort of SUNRISE-PD study

June 7, 2019

In vitro study identifies factors responsible for the SPARCL of youth

June 7, 2019

New mGlu2 negative allosteric modulators synthesized at Sumitomo Dainippon Pharma

June 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.